Home Pfizer

Pfizer

Looking to expand your partner network with leading companies like Pfizer? Consider joining Inpart's global network for free.

Stay informed about the latest news about Pfizer by subscribing to our newsletter.

What is Pfizer best known for?

Pfizer is a leading pharmaceutical company known for pioneering drug development, vaccines, and advancements in cardiovascular health, oncology, immunology, and infectious diseases. Its COVID-19 vaccine has received global acclaim for effectively combating the pandemic.

Where is Pfizer located?

Pfizer has its global headquarters in New York City, United States. However, the company operates in numerous countries worldwide, with research and manufacturing facilities located in various regions.

Got a news story for us related to Pfizer? Send it to us here.

Latest Posts

In Depth 25 Sep 2024

How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market

Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the ’90s.

September 25, 2024 - 9 minutesmins - By Jennifer Tsang

Pfizer Flagship alliance: a new era in pharma partnership models?

In Depth 24 Sep 2024

New partnership model on the rise: how VCs are helping Pharma hunt for their next blockbuster

Discover how the recent Pfizer-Flagship alliance model sets a trend in pharma-VC partnerships, fostering innovation in drug development.

September 24, 2024 - 9 minutesmins - By Monica Karpinski

In Depth 24 Jul 2024

Danuglipron: Is Pfizer’s oral weight loss pill a contender in the obesity market?

Find out more about Pfizer’s GLP-1 candidate danuglipron, as the company aims to compete in the obesity market.

July 24, 2024 - 10 minutesmins - By Willow Shah-Neville

In Depth 5 Jun 2024

Evolving standards of care: new treatments for cervical cancer

New treatments for cervical cancer aim to broaden therapeutic options, and improve current standards of care for patients.

June 5, 2024 - 7 minutesmins - By Roohi Mariam Peter

In Depth 8 Feb 2024

Could we see a new dawn for hair loss treatments?

Discover the latest advances in hair loss treatments, from topical therapies to the the groundbreaking potential of JAK inhibitors.

February 8, 2024 - 8 minutesmins - By David Cox

News and Trends 21 Dec 2023

The big pharma race against deadly RSV steps up in 2023

GSK and Pfizer received FDA approval for their RSV vaccines in 2023. Now, AstraZeneca has joined the race with its latest acquisition.

December 21, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 12 Jul 2023

Pfizer kicks $25M into CellCentric

U.K.-based biotechnology company CellCentric has received a strategic investment from Pfizer including $25 million to help finance further development of inobrodib, its first-in-class p300/CBP inhibitor to treat specific types of cancer. Pfizer will support CellCentric with its own clinical development program in multiple myeloma (MM) for 2024, alongside ongoing trials in specific hematological malignancies, through […]

July 12, 2023 - 3 minutesmins - By Jim Cornall

More News! 6 Jun 2023

$5.5M funding for Oncopole to tackle cancer

Oncopole, Fonds de recherche du Québec – Santé (FRQS) cancer division in Canada, has received major investments that boost its public-private partnership model dedicated to the fight against cancer. Oncopole will continue to pursue its mission thanks to a $3 million reinvestment from founding partner Merck Canada. Oncopole, FRQS cancer division, is the result of […]

June 6, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 19 May 2023

Google Cloud adds AI solutions for drug discovery

Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. The Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and […]

May 19, 2023 - 6 minutesmins - By Jim Cornall

News and Trends 5 May 2023

Promising results from phase 3 prostate cancer study

Astellas Pharma Inc. and Pfizer Inc. have announced trial results from a phase 3 study on prostate cancer. The results showed XTANDI (enzalutamide) plus leuprolide significantly reduced the risk of metastasis or death by 58% versus placebo plus leuprolide, as assessed by the primary endpoint of metastasis-free survival (MFS) in men with non-metastatic hormone-sensitive prostate […]

May 5, 2023 - 4 minutesmins - By Jim Cornall

In Depth 18 Apr 2023

Gene therapy: a powerful tool for hemophilia B?

The approval of HEMGENIX, the first-ever gene therapy for hemophilia B, by the U.S. Food and Drug Administration (FDA) followed by the European Commission, has been momentous in rare disease therapeutic research, paving the way for various gene therapies that are currently being studied. As we observed World Hemophilia Day on April 17, let us […]

April 18, 2023 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 14 Mar 2023

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline

Pfizer Inc. is set to acquire Seagen Inc. for $229 in cash per Seagen share for a total enterprise value of $43 billion. Seagen is a global biotechnology company that discovers, develops and commercializes cancer medicines. The boards of directors of both companies have unanimously approved the transaction. “Pfizer is deploying its financial resources to […]

March 14, 2023 - 6 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Pfizer

What is Pfizer best known for?

Where is Pfizer located?

How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market

New partnership model on the rise: how VCs are helping Pharma hunt for their next blockbuster

Danuglipron: Is Pfizer’s oral weight loss pill a contender in the obesity market?

Evolving standards of care: new treatments for cervical cancer

Could we see a new dawn for hair loss treatments?

The big pharma race against deadly RSV steps up in 2023

Pfizer kicks $25M into CellCentric

$5.5M funding for Oncopole to tackle cancer

Google Cloud adds AI solutions for drug discovery

Promising results from phase 3 prostate cancer study

Gene therapy: a powerful tool for hemophilia B?

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!